glp 1 drug price reduction The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs KFF Health Tracking Poll: Prescription

According to the FDA label, GLP-1 is a physiological regulator of appetite and calorie intake, and its receptor sits in several areas of the brain involved in appetite regulation

Hsieh, C

Biochemistry (2011) 50(37):790918

2009;587(Pt 19):47494759

As weight loss with any existing pharmaceutical intervention inevitably plateaus due to putative counterregulatory mechanisms, we further hypothesized that the postulated enhanced body weight suppressive effects of combined amylin- and GLP-1R-based pharmacotherapies could be even further enhanced if the drugs were introduced in a stepwise fashion, allowing the physiological systems to adjust to and overcome the tachyphylaxis that occurs with repeated drug treatments 21,22,23

Third, heterogeneity in study designs, primary endpoints, and biomarker assessments limits direct comparability and generalizability